PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q1 2023. The put-call ratio across all filers is 8.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $75 | -29.2% | 25,600 | -29.7% | 0.00% | – |
| Q4 2022 | $106 | -99.9% | 36,400 | -22.6% | 0.00% | – |
| Q3 2022 | $113,000 | -19.3% | 47,000 | -24.2% | 0.00% | – |
| Q2 2022 | $140,000 | -22.2% | 62,000 | -20.6% | 0.00% | – |
| Q1 2022 | $180,000 | -7.7% | 78,100 | 0.0% | 0.00% | – |
| Q4 2021 | $195,000 | -54.0% | 78,100 | -41.5% | 0.00% | – |
| Q3 2021 | $424,000 | – | 133,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,061,411 | $2,378,000 | 1.62% |
| Ayrton Capital LLC | 153,130 | $343,000 | 0.56% |
| Shay Capital LLC | 982,698 | $2,201,000 | 0.44% |
| EQUITEC PROPRIETARY MARKETS, LLC | 342,994 | $768,000 | 0.22% |
| FNY Investment Advisers, LLC | 15,290 | $34,000 | 0.02% |
| K2 PRINCIPAL FUND, L.P. | 91,095 | $204,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 26,200 | $59,000 | 0.00% |
| Aspire Private Capital, LLC | 800 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,758 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,734 | $4,000 | 0.00% |